Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
NOV-205
DRUG
2 trials
Sponsors
Cellectar Biosciences, Inc.
Conditions
Hepatitis C
Phase 1
Safety and PK Study of NOV-205 to Treat Chronic HCV Who Fail Standard Therapy
Completed
NCT00372983
Cellectar Biosciences, Inc.
Hepatitis C
Start: 2006-08-31
End: 2007-12-31
Target: 30
Updated: 2007-12-21
Phase 2
A Trial of NOV-205 in Hepatitis C Patients Who Failed Standard Therapy
Completed
NCT01058512
Cellectar Biosciences, Inc.
Hepatitis C
Start: 2010-03-31
End: 2010-12-31
Updated: 2022-07-25